Christophe Drieu La Rochelle

Author

Also Known As

C D la Rochelle, C Drieu La Rochelle, C Drieu la Rochelle, C. Drieu La Rochelle, C. Drieu la Rochelle, Christophe Drieu La Rochelle, Christophe Drieu la Rochelle, Christophe Drieu La Rochelle, Cierra Rochelle

Publications

1.8K

Citations

H-Index

Concepts

All Affiliations

Université Paris-Sud Structure Fédérative de Recherche en Biologie et Santé de Rennes Bicêtre Hospital Centre National de la Recherche Scientifique Université de Rennes

About

Christophe Drieu La Rochelle is an author at Université Paris-Sud specializing in medicine, pharmacology, and physiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	13	866
2	Social Sciences	4	4	305
3	Anesthesia	3	3	94
4	Health Sciences	2	2	69
5	Public Health	1	1	49

Christophe Drieu La Rochelle

Publications

1.7K

Citations

H-Index

Page 1

	Year	Citations
Translocator Protein (18 kD) as Target for Anxiolytics Without Benzodiazepine-Like Side Effects Rainer Rupprecht, Gerhard Rammes, Daniela Eser, Science Drug TargetBiochemistryTranslocator ProteinMedicinePsychotropic Medication	2009	319
BF2.649 [1-{3-[3-(4-Chlorophenyl)propoxy]propyl}piperidine, Hydrochloride], a Nonimidazole Inverse Agonist/Antagonist at the Human Histamine H3 Receptor: Preclinical Pharmacology Xavier Ligneau, David Perrin, Laurent Landais, Journal of Pharmacology and Experimental Therapeutics	2006	233
The object recognition task in rats and mice: A simple and rapid model in safety pharmacology to detect amnesic properties of a new chemical entity Valérie Bertaina‐Anglade, E. Enjuanes, D. Morillon, Journal of Pharmacological and Toxicological Methods Safety PharmacologyCognitive ScienceBehavioral NeuroscienceMedicinePharmacology	2006	166
<i>Arenicola marina</i> extracellular hemoglobin: a new promising blood substitute M Rousselot, Eric Delpy, Christophe Drieu La Rochelle, Biotechnology Journal	2006	129
Antidepressant-like effects of agomelatine (S 20098) in the learned helplessness model Valérie Bertaina‐Anglade, Christophe Drieu La Rochelle, Pierre‐Alain Boyer, Behavioural Pharmacology Learned Helplessness ModelPsychopharmacologyMental HealthSocial SciencesPsychology	2006	118
S33005, a Novel Ligand at Both Serotonin and Norepinephrine Transporters: II. Behavioral Profile in Comparison with Venlafaxine, Reboxetine, Citalopram, and Clomipramine Mark J. Millan, Anne Dekeyne, Mariusz Papp, Journal of Pharmacology and Experimental Therapeutics	2001	116
Role of vascular endothelium in exercise-induced dilation of large epicardial coronary arteries in conscious dogs. Alain Berdeaux, Bijan Ghaleh, J.-L. Dubois-Randé, Circulation	1994	99
Cognition-Enhancing Properties of Dimebon in a Rat Novel Object Recognition Task Are Unlikely to Be Associated with Acetylcholinesterase Inhibition or N-Methyl-d-aspartate Receptor Antagonism Marco Giorgetti, Jacqueline A. Gibbons, Sebastián Bernales, Journal of Pharmacology and Experimental Therapeutics	2010	67
S32504, a Novel Naphtoxazine Agonist at Dopamine D3/D2 Receptors: III. Actions in Models of Potential Antidepressive and Anxiolytic Activity in Comparison with Ropinirole Mark J. Millan, Mauricette Brocco, Mariusz Papp, Journal of Pharmacology and Experimental Therapeutics	2004	53
Regional coronary haemodynamic effects of two inhibitors of nitric oxide synthesis in anaesthetized, open‐chest dogs Vincent Richard, Alain Berdeaux, Christophe Drieu La Rochelle, British Journal of Pharmacology Cardiac AnaesthesiaNitric OxideCardiovascular PharmacologyPharmacotherapyCardiovascular Function	1991	49

Page 1